Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK
- 20 January 2015
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 8 (360) , ra6
Abstract
Heparin binds and activates the receptor tyrosine kinase ALK, which has no known ligand.Keywords
Funding Information
- Kolltan Pharmaceuticals
This publication has 19 references indexed in Scilit:
- Anaplastic Lymphoma Kinase Spares Organ Growth during Nutrient Restriction in DrosophilaCell, 2011
- Anaplastic Thyroid Cancers Harbor Novel Oncogenic Mutations of the ALK GeneCancer Research, 2011
- Proteoglycan-Specific Molecular Switch for RPTPσ Clustering and Neuronal ExtensionScience, 2011
- Cell Signaling by Receptor Tyrosine KinasesCell, 2010
- Protein structure prediction on the Web: a case study using the Phyre serverNature Protocols, 2009
- In contrast to agonist monoclonal antibodies, both C-terminal truncated form and full length form of Pleiotrophin failed to activate vertebrate ALK (anaplastic lymphoma kinase)?Cellular Signalling, 2007
- Activation and Inhibition of Anaplastic Lymphoma Kinase Receptor Tyrosine Kinase by Monoclonal Antibodies and Absence of Agonist Activity of PleiotrophinJournal of Biological Chemistry, 2005
- ALK receptor tyrosine kinase promotes cell growth and neurite outgrowthJournal of Cell Science, 2004
- Kinetic Model for FGF, FGFR, and Proteoglycan Signal Transduction Complex AssemblyBiochemistry, 2004
- The Human Genome Browser at UCSCGenome Research, 2002